National Research Institute of Chinese Medicine, Ministry of Health and Welfare

Taiwan, Province of China

Back to Profile

1-7 of 7 for National Research Institute of Chinese Medicine, Ministry of Health and Welfare Sort by
Query
Aggregations
IP Type
        Patent 5
        Trademark 2
Date
2023 3
2021 2
2020 2
IPC Class
A61K 36/539 - Scutellaria (skullcap) 3
A61K 36/575 - Magnolia 3
A61K 36/076 - Poria 2
A61K 36/282 - Artemisia, e.g. wormwood or sagebrush 2
A61K 36/428 - Trichosanthes 2
See more
Status
Pending 3
Registered / In Force 4
Found results for

1.

Composition and method for treating cancer

      
Application Number 17993343
Grant Number 12076355
Status In Force
Filing Date 2022-11-23
First Publication Date 2023-06-01
Grant Date 2024-09-03
Owner
  • National Yang Ming Chiao Tung University (Taiwan, Province of China)
  • National Research Institute of Chinese Medicine, Ministry of Health and Welfare (Taiwan, Province of China)
Inventor
  • Lin, Tung-Yi
  • Lu, Mei-Kuang

Abstract

Antrodia cinnamomea cultured in the presence of zinc sulfate and a carrier thereof, wherein the polysaccharide includes glucose and fucose. Also provided are a method for preparing the composition and a composition including the polysaccharide fraction obtained therefrom.

IPC Classes  ?

  • A61K 36/07 - Basidiomycota, e.g. Cryptococcus
  • A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
  • A61P 35/00 - Antineoplastic agents

2.

PLANT COMPOSITION, TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF

      
Application Number 18047697
Status Pending
Filing Date 2022-10-19
First Publication Date 2023-04-20
Owner NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taiwan, Province of China)
Inventor
  • Su, Yi-Chang
  • Chiou, Wen-Hui
  • Shen, Yuh-Chiang
  • Wei, Wen-Chi
  • Tsai, Keng-Chang
  • Liao, Chia-Ching
  • Tseng, Yu-Hwei
  • Chiou, Chun-Tang
  • Lin, Yu-Chi
  • Wang, Li-Hsiang

Abstract

The present invention relates to a plant composition, a traditional Chinese medicine composition and use thereof. The plant composition comprises Prepared Monkshood Daughter Root (Aconitum carmichaelii), Fragrant Solomonseal Rhizome (Polygonatum odoratum), Indian Bread (Poria cocos), Pinellia tuber (Pinellia ternata), Oriental Wormwood Herb (Artemisia scoparia), Scutellaria Root (Scutellaria baicalensis), Mongolian Snakegourd Fruit (Trichosanthes kirilowii), Magnolia Bark (Magnolia officinalis), Heartleaf Houttuynia Herb (Houttuynia cordata) and Baked Licorice Root and Rhizome (Glycyrrhiza glabra), which is used as a traditional Chinese medicine composition. In addition, the traditional Chinese medicine composition can be used to treat pulmonary embolism or pulmonary fibrosis.

IPC Classes  ?

3.

USE OF PLANT COMPOSITION, TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARING MEDICINE FOR TREATING COVID-19

      
Application Number 18047712
Status Pending
Filing Date 2022-10-19
First Publication Date 2023-04-20
Owner NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taiwan, Province of China)
Inventor
  • Su, Yi-Chang
  • Chiou, Wen-Hui
  • Shen, Yuh-Chiang
  • Wei, Wen-Chi
  • Tsai, Keng-Chang
  • Liao, Chia-Ching
  • Tseng, Yu-Hwei
  • Chiou, Chun-Tang
  • Lin, Yu-Chi
  • Wang, Li-Hsiang
  • Huang, Chien-Hsien
  • Lin, Chia-Mo
  • Lin, Chi-Kuei
  • Huang, Yi-Chia
  • Lin, Chien-Jung
  • Lin, Jui-Shan
  • Yang, Ya-Sung
  • Chiu, Chun-Hsiang
  • Cheng, Shun-Ping
  • Kuo, Hsien-Hwa
  • Lin, Wu-Pu
  • Lin, Chen-Shien
  • Lai, Bo-Cheng
  • Hsu, Yuan-Nian
  • Tsai, Tsung-Lung
  • Hsu, Wei-Chen
  • Fong, Tieng-Siong
  • Huang, Yi-Wen
  • Tsai, Chia-I
  • Yang, Ya-Chen
  • Tsai, Ming-Che
  • Cheng, Ming-Huei
  • Huang, Shih-Wei

Abstract

The present invention relates to a method of treating moderate or severe symptoms of COVID-19 using a plant composition. The plant composition comprises Prepared Monkshood Daughter Root (Aconitum carmichaelii), Fragrant Solomonseal Rhizome (Polygonatum odoratum), Indian Bread (Poria cocos), Pinellia tuber (Pinellia ternata), Oriental Wormwood Herb (Artemisia scoparia), Scutellaria Root (Scutellaria baicalensis), Mongolian Snakegourd Fruit (Trichosanthes kirilowii), Magnolia Bark (Magnolia officinalis), Heartleaf Houttuynia Herb (Houttuynia cordata), and Baked Licorice Root and Rhizome (Glycyrrhiza glabra), which is used as a traditional Chinese medicine composition.

IPC Classes  ?

4.

NRICM102

      
Serial Number 97142645
Status Pending
Filing Date 2021-11-24
Owner NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taiwan, Province of China)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Chinese traditional medicinal herbs; Vitamin supplements; Calcium supplements; Food supplements; Mineral supplements; Herbal supplements; Prebiotic supplements; Dietary supplements; Nutritional supplements; Protein supplements; Enzyme food supplements; Powdered milk for babies; Food for babies; First-aid boxes, filled; Medicated shampoos

5.

Composition of plant ingredients, herbal composition and preparation method of the herbal composition

      
Application Number 17128234
Grant Number 11331362
Status In Force
Filing Date 2020-12-21
First Publication Date 2021-11-18
Grant Date 2022-05-17
Owner NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taiwan, Province of China)
Inventor
  • Su, Yi-Chang
  • Chiou, Wen-Hui
  • Kuo, Yao-Haur
  • Tsai, Keng-Chang
  • Liao, Chia-Ching
  • Wei, Wen-Chi
  • Chiou, Chun-Tang
  • Yeh, Kuo-Ming
  • Huang, Yi-Chia
  • Lin, Chien-Jung
  • Lin, Jui-Shan

Abstract

A composition of plant ingredients, a herbal composition for inhibiting coronavirus and cytokine storm, and a preparation method of the herbal composition are introduced. The composition of plant ingredients has Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root. The herbal composition has 1 to 20 parts by weight of Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root. The preparation method contains providing Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root; and soaking all the herbs described above in water and boiling the water to prepare a herbal liquid, the volume of which is about one-third of an initial volume of the water.

IPC Classes  ?

6.

NRICM101

      
Serial Number 90084772
Status Registered
Filing Date 2020-07-31
Registration Date 2021-08-17
Owner NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taiwan, Province of China)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Chinese traditional medicinal herbs; vitamin supplements; calcium supplements; food supplements; mineral supplements; herbal supplements; prebiotic supplements; dietary supplements; nutritional supplements; protein supplements; enzyme food supplements

7.

Anti-EGF like domain multiple 6 (EGFL6) antibodies

      
Application Number 16652929
Grant Number 11578121
Status In Force
Filing Date 2018-09-28
First Publication Date 2020-07-30
Grant Date 2023-02-14
Owner
  • Taipei Medical University (Taiwan, Province of China)
  • Changhua Christian Medical Foundation Changhua Christian Hospital (Taiwan, Province of China)
  • National Research institute of Chinese Medicine, Ministry of Health and Welfare (Taiwan, Province of China)
Inventor
  • Lee, Yu-Ching
  • Pan, Shiow-Lin
  • Huangfu, Wei-Chun
  • Huang, Tsui-Chin
  • Wei, Po-Li
  • Huang, Han-Li
  • Cheng, Chun-Chun
  • Huang, Cheng-Chiao
  • Tsai, Keng-Chang
  • Yeh, Kun-Tu
  • Sung, Ting-Yi
  • Chang, Fu-Ling

Abstract

The invention relates to anti-EGF like domain multiple 6 antibody (anti-EGFL6 antibody) and cancer detection (or diagnosis) and treatment using the anti-EGFL6 antibody. The present invention creates anti-EGFL6 antibodies, particularly, a single-chain antibody fragments (scFv) and humanized antibody, which have ability in binding to EGFL6 and in inhibiting angiogenesis and cancer cell growth.

IPC Classes  ?

  • A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
  • C07K 16/22 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies